CFDA: Meeting of Delegations of EU Commission and CFDA in Beijing

15. April 2016

As announced on the website of the China Food and Drug Administration (CFDA) a meeting of the EU-China Working Group on pharmaceuticals was held in Beijing on March 9, 2016. The European Commission delegation was headed by Mr. Andrzej Rys, director of Directorate-General for Health and Food Safety (DG SANTE) of the European Commission, and Mr. Guido Rasi, executive director of the European Medicines Agency (EMA).

Both sides had in-depth discussions on the reform of China and EU drug evaluation and approval system, international multi-center clinical trial, anti-counterfeiting legislation of EU, management of online pharmacy, participation in relevant international coordination mechanisms, and cooperation in review and evaluation etc.

CFDA and the European Commission signed the Consultation and Cooperation Mechanism in 2013, and agreed to regularly have constructive dialogues on pharmaceutical laws and regulations and explore the possibility of cooperation in the field of coordination and standards.

If you want to learn more about CFDA certification for medical devices, products and pharmaceuticals, please visit the CFDA section on our website. We also provide more detailed knowledge regarding CFDA in our free brochure “CFDA China – The Booklet” that can be downloaded here.

Please do not hesitate to call (UK: +44 2071931135, Rest of Europe: +49 69 2713769150, US: +1 773 654-2673) or email and we will be happy to answer questions.